From: Weighted EHR-based prevalence estimates for hypertension at the state and local levels in Louisiana
MENDS (2023) | BRFSS (2021, [38]) | Ìý | ||||
---|---|---|---|---|---|---|
Group n = 785,999 patients | Percentage of Patients | a. Weighted Hypertension Prevalence (95% CI) | Group n = 5,081 respondents | Percentage of Respondents | b. Hypertension Awarenessa (95% CI) | Percent Differenceb (a-b)/b |
Overall | Ìý | 43.0% (42.7%–43.3%) | Overalla | 100.0% | 37.3% (35.6%–39.1%) | 13.3% |
Sex | Ìý | Ìý | Sex | Ìý | Ìý | Ìý |
 M²¹±ô±ð | 41.8% | 47.3% (46.8%–47.7%) | Male | 44.9% | 41.5% (38.8%–44.2%) | 14.0% |
 F±ð³¾²¹±ô±ð | 58.2% | 39.1% (38.7%–39.5%) | Female | 55.1% | 39.1% (36.7%–41.5%) | 5.6% |
Age Group (years) | Ìý | Ìý | Age Group (years) | Ìý | Ìý | Ìý |
 20–44 | 41.0% | 25.1% (24.7%–25.6%) | 18–24 | 1.0% | 11.3% (5.2%–17.3) | 0.5%c |
25–34 | 9.7% | 17.3% (13.2%–21.3%) | ||||
35–44 | 13.5% | 29.5% (25.3%–33.7%) | ||||
 45–64 | 34.5% | 53.3% (52.7%–53.8%) | 45–54 | 17.2% | 43.5% (39.4%–47.6%) | 4.3%c |
55–64 | 20.0% | 55.6% (51.9%–59.4%) | ||||
 65–84 | 24.5% | 68.3% (67.5%–69.0%) | 65 +  | 33.7% | 68.9% (66.0%–71.9%) | −0.9% |
Race and Ethnicity | Ìý | Ìý | Race and Ethnicity | Ìý | Ìý | Ìý |
 Non-Hispanic Asian | 1.6% | 31.0% (30.0%–31.9%) | Asian | 1.0% | Not available | Not available |
 Non-Hispanic Black | 30.4% | 50.2% (49.6%–50.9%) | Black | 21.2% | 46.7% (42.8%–50.6%) | 7.5% |
‽ö¾±²õ±è²¹²Ô¾±³¦ | 5.1% | 33.4% (32.4%–34.3%) | Hispanic | 3.5% | 32.5% (23.0%–42.1%) | 2.8% |
 Non-Hispanic White | 61.5% | 41.1% (40.7%–41.5%) | White | 70.4% | 38.4% (36.4%–40.4%) | 7.0% |
Ìý | Ìý | Ìý | Native Hawaiian or Pacific Islander | 0.2% | Not available | Not available |
Ìý | Ìý | Ìý | American Indian or Alaska Native | 1.1% | 33.1% (17.2%–49.1%) | |
Ìý | Ìý | Ìý | Multiracial | 1.7% | 32.3% (18.9%–45.7%) | |
 O³Ù³ó±ð°ù | 1.5% | 34.0% (32.7%–35.2%) | Other | 0.9% | Not available |